`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`ARGENTUM PHARMACEUTICALS LLC
`Petitioner
`
`v.
`
`RESEARCH CORPORATION TECHNOLOGIES, INC.
`Patent Owner
`
`Patent No. RE38,551
`Issue Date: Jul. 6, 2004
`Title: ANTICONVULSANT ENANTIOMERIC AMINO ACID DERIVATIVES
`_______________
`
`Case No. IPR2016-00204
`____________________________________________________________
`
`
`
`PETITIONER’S UPDATED MANDATORY NOTICES
`
`37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`Patent No. RE 38,551
`
`
`
`Case No. IPR2016-00204
`
`Petitioner hereby updates its mandatory notices pursuant to 37 C.F.R. § 42.8(b)
`
`as follows:
`
`Real Parties-In-Interest – 37 C.F.R. § 42.8(b)(1)
`1.
`
`After the Petition in this proceeding was filed, and within 21 days of
`
`today’s notice, Argentum Pharmaceuticals LLC entered into a collaboration
`
`agreement with KVK-TECH, Inc. (“KVK”) for the purpose of jointly
`
`commercializing generic pharmaceutical products. At this time, KVK is not a real
`
`party-in-interest with respect to this proceeding (a “highly fact-dependent
`
`question,” Trial Practice Guide at 48759) but may in the future, at which time
`
`Petitioner will affirmatively name KVK as such party in an updated notice.
`
`Nevertheless, Petitioner wishes to bring this development to the Board’s attention
`
`in the interest of full disclosure. See Press Release, Feb. 1, 2016, at
`
`http://www.prnewswire.com/news-releases/kvk-tech-and-argentum-
`
`pharmaceuticals-announce-partnership-to-commercialize-pharmaceutical-products-
`
`made-in-the-usa-300213451.html.
`
`2.
`
`After the Petition in this proceeding was filed, and within 21 days of
`
`today’s notice, APS GP Investors LLC became a real party-in-interest with respect
`
`to this proceeding.
`
`-2-
`
`
`
`Patent No. RE 38,551
`
`
`
`Case No. IPR2016-00204
`
`Certification – 37 C.F.R. § 42.104(a)
`
`Petitioner certifies that none of the above-named entities were served with a
`
`complaint alleging infringement of the captioned patent more than 1 year prior to
`
`this notice and are not otherwise barred or estopped from requesting an inter partes
`
`review challenging the patent claims on the grounds identified in the Petition.
`
`/Matthew J. Dowd/
`Matthew J. Dowd
`Reg. No. 47,534
`ANDREWS KURTH LLP
`1350 I Street, N.W., Suite 1100
`Washington, DC 20005
`Phone: (202) 662-2701
`Fax: (202) 974-9511
`matthewdowd@andrewskurth.com
`
`Justin W. Crotty, Ph.D.
`Reg. No. 68,937
`ANDREWS KURTH LLP
`1350 I Street, NW, Suite 1100
`Washington, DC 20005
`Phone : 202.662.3007
`Fax: 202.974.9538
`JustinCrotty@andrewskurth.com
`
`Counsel for Petitioner
`
`
`
`
`
`Dated: February 10, 2016,
`
`By:
`
`
`
`
`
`
`
`
`
`-3-
`
`
`
`Patent No. RE 38,551
`
`
`
`Case No. IPR2016-00204
`
`CERTIFICATE OF SERVICE
`
`
`The undersigned hereby certifies that a copy of the foregoing Petitioner’s
`
`Updated Mandatory Notices was served via email at the following addresses:
`
`
`jrobbins@cov.com
`areister@cov.com
`rlongton@cov.com
`
`
`
`/Matthew J. Dowd/
`Matthew J. Dowd
`Reg. No. 47,534
`ANDREWS KURTH LLP
`1350 I Street, NW
`Suite 1100
`Washington, DC 20005
`Phone: (202) 662-2701
`Fax: (202) 974-9511
`matthewdowd@andrewskurth.com
`
`By: